Thomas A. Zalewski
CIK: 0002127796
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AQST
Aquestive Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Zalewski Thomas A.
Zalewski Thomas A. (SEC CIK 0002127796) files insider reports with the SEC as Chief Legal Officer of Aquestive Therapeutics, Inc. (AQST).
Signal8 holds 2 ownership filings by Zalewski Thomas A. (1 Form 3, 1 Form 4), filed between Apr 10, 2026 and May 19, 2026. Those filings report 1 transaction, the latest on May 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zalewski Thomas A.'s filings is in WARREN, NJ.
Recent filings by Zalewski Thomas A.
- May 18, 2026: Grant or award of AQST shares (Form 4, code A).
Other insiders filing for Aquestive Therapeutics, Inc. (AQST)
- Cochran John, Director
- Barber Daniel, President and CEO
- Daly Richard J, Director
- Korczynski Sherry, Chief Commercial Officer
- Boyd Peter E., Chief People Officer
- Jung Cassie, Chief Operating Officer